iMAX Diagnostic Imaging Overview

  • Year Founded
  • 2011

Year Founded

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • M&A

  • Financing Rounds
  • 1

iMAX Diagnostic Imaging General Information

Description

Manufacturer of generics, active pharmaceutical ingredients and drug products. The company is engaged in the wholesale distribution of prescription drugs, proprietary drugs, and toiletries, thereby offering drug products with full integration of the supply chain from raw materials, chemical engineering and post-processing.

Contact Information

Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Corporate Backed or Acquired
Corporate Office
  • Phoenix House, Room 137
  • Monahan Road
  • Cork T12 H1XY
  • Ireland
Primary Industry
Other Pharmaceuticals and Biotechnology
Other Industries
Specialty Chemicals
Parent Company
Vertical(s)
Corporate Office
  • Phoenix House, Room 137
  • Monahan Road
  • Cork T12 H1XY
  • Ireland

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

iMAX Diagnostic Imaging Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore iMAX Diagnostic Imaging‘s full profile, request access.

Request a free trial

iMAX Diagnostic Imaging Patents

iMAX Diagnostic Imaging Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20150025275-A1 Iodination process for the preparation of 3, 5-disubstituted-2, 4, 6-triiodo aromatic amines compounds Active 31-Oct-2011
US-9382194-B2 Iodination process for the preparation of 3, 5-disubstituted-2, 4, 6-triiodo aromatic amines compounds Active 31-Oct-2011
AU-2011380449-A1 Iodination process for the preparation of 3,5-disubstituted-2,4,6-triiodo aromatic amines compounds Active 31-Oct-2011
AU-2011380449-A8 Iodination process for the preparation of 3,5-disubstituted-2,4,6-triiodo aromatic amines compounds Active 31-Oct-2011
AU-2011380449-B2 Iodination process for the preparation of 3,5-disubstituted-2,4,6-triiodo aromatic amines compounds Active 31-Oct-2011 C07C231/12
To view iMAX Diagnostic Imaging’s complete patent history, request access »

iMAX Diagnostic Imaging Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore iMAX Diagnostic Imaging‘s full profile, request access.

Request a free trial

iMAX Diagnostic Imaging FAQs

  • When was iMAX Diagnostic Imaging founded?

    iMAX Diagnostic Imaging was founded in 2011.

  • Where is iMAX Diagnostic Imaging headquartered?

    iMAX Diagnostic Imaging is headquartered in Cork, Ireland.

  • What industry is iMAX Diagnostic Imaging in?

    iMAX Diagnostic Imaging’s primary industry is Other Pharmaceuticals and Biotechnology.

  • Is iMAX Diagnostic Imaging a private or public company?

    iMAX Diagnostic Imaging is a Private company.

  • What is iMAX Diagnostic Imaging’s current revenue?

    The current revenue for iMAX Diagnostic Imaging is .

  • Who are iMAX Diagnostic Imaging’s investors?

    Hovione has invested in iMAX Diagnostic Imaging.

  • When was iMAX Diagnostic Imaging acquired?

    iMAX Diagnostic Imaging was acquired on 07-Mar-2018.

  • Who acquired iMAX Diagnostic Imaging?

    iMAX Diagnostic Imaging was acquired by Starry Pharmaceutical.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process